EichorEICHOR
Study identifier: NCT05556512 Synced from ClinicalTrials.gov · August 02, 2026
● Active Not Recruiting

A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

Condition: Obesity · Overweight  ·  Sponsor: Eli Lilly and Company

PhasePhase 3
Planned participants15374
Who can joinAll sexes, 40 Years to no upper limit
Healthy volunteersNo

About this study

This study will investigate the effect of tirzepatide on the reduction of morbidity and mortality in adults living with obesity and provide additional evidence for the potential clinical benefits of tirzepatide in this population.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (671)

Prime Medical Group, LLC dba Gilbert Center for Family Medicine, LLCGilbert, Arizona, United States
Aventiv ResearchMesa, Arizona, United States
Elite Clinical StudiesPhoenix, Arizona, United States
Pima HeartTucson, Arizona, United States
KLR Business Group, Inc. dba Arkansas Clinical ResearchLittle Rock, Arkansas, United States
Smart Cures Clinical ResearchAnaheim, California, United States
Kidney & Hypertension Center - Apple ValleyApple Valley, California, United States
Hope Clinical Research, Inc.Canoga Park, California, United States
John Muir Physician Network Research CenterConcord, California, United States
Neighborhood Healthcare Institute of HealthEscondido, California, United States
HB Clinical Trials - Fountain ValleyFountain Valley, California, United States
Valiance Clinical ResearchHuntington Park, California, United States

+ 659 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →